Digital Polymerase Chain Reaction (dPCR) Instrument

AMENDMENT 0001:  The purpose of this amendment is to change the competitive set-aside status to Unrestricted and to extend the quotation due date to Monday, September 28, 2026, no later than 10:00 a.m. CDT.

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Part 12.  This announcement constitutes the only solicitation.  Quotations are being requested and a separate written solicitation will not be issued. 

Solicitation number 1232SA26Q0695 is issued as a Request for Quotation (RFQ) for procurement and delivery of one (1) Digital Polymerase Chain Reaction (dPCR) Instrument supported in strict accordance .... Read More

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Part 12.  This announcement constitutes the only solicitation.  Quotations are being requested and a separate written solicitation will not be issued. 

Solicitation number 1232SA26Q0695 is issued as a Request for Quotation (RFQ) for procurement and delivery of one (1) Digital Polymerase Chain Reaction (dPCR) Instrument supported in strict accordance with the specifications outlined in Statement of Requirements attachment.

This acquisition  is set-aside for small business concerns.  The applicable North American Industry Classification Standard Code is 334516  The small business size standard is 1,000 in number of employees.  This acquisition is a Total Small Business Set-Aside.  All responsible sources may submit a quotation which will be considered by the agency.